About
Develops products for JT Pharmaceuticals
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Team (11)
Barbara Gerhardt, R.Ph.
Senior Director, Clinical Operations
Akros Pharma
team_member
Kala Patel, R.Ph.,RAC.
Senior Director, Regulatory Affairs
Akros Pharma
team_member
Keisuke Nozawa, Ph.D.
Senior Director, Research Alliance
Akros Pharma
team_member
Koji Hanaki, M.S.
Senior Director, Project Management
Akros Pharma
team_member
Kristin Williams, MHRM
Senior Director, Human Resource
Akros Pharma
team_member
Rui Zhuo, Ph.D.
Senior Director, Clinical Data Sciences
Akros Pharma
team_member
Clinical Trials (25)
View allTotal Trials
25
As Lead Sponsor
25
As Collaborator
0
Total Enrollment
2,782
By Phase
PHASE2: 13PHASE1: 12
By Status
COMPLETED: 19TERMINATED: 4RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline25 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06017609Lead Sponsor
Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction
PHASE2Recruiting
300 participants
Started: Dec 20, 2023 · Completed: Feb 28, 2027
NCT04465877Lead Sponsor
Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of JTT-662 in Subjects With Type 2 Diabetes
PHASE1Completed
37 participants
Started: Jun 15, 2020 · Completed: Feb 17, 2021
NCT03789643Lead Sponsor
Study to Evaluate Efficacy and Safety of JTT-251 in Participants With Pulmonary Arterial Hypertension
PHASE2Withdrawn
Started: Mar 31, 2019 · Completed: Jun 30, 2021
NCT03832738Lead Sponsor
Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis
PHASE2Completed
152 participants
Started: Jan 17, 2019 · Completed: Mar 13, 2020
NCT03358290Lead Sponsor
Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis
PHASE2Terminated
13 participants
Started: Nov 10, 2017 · Completed: Oct 29, 2018
Locations (1)
Headquarters
Princeton, NJ, United States
Map
Loading map...